Advertisement

Magenkarzinom

  • Martin Werner
  • Karl Friedrich Becker
  • Knut Böttcher
  • Gisela Keller
  • Heinz Höfler
Chapter
Part of the Molekulare Medizin book series (MOLMED)

Zusammenfassung

In Deutschland versterben jährlich etwa 15000 Patienten an Magenkarzinom. Die leicht rückläufigen Magenkarzinome sind damit unter den 5 häufigsten krebsbedingten Todesursachen (Engel et al. 1997). Eine kurative Behandlung dieser häufig erst im fortgeschrittenen Stadium diagnostizierten Tumoren ist lediglich durch eine komplette chirurgische Entfernung möglich. Jedoch sind auch bei mikroskopisch gesicherter kompletter Resektion des Karzinoms (so genannte RO-Resektion) hohe Rezidivraten üblich. Die häufig auftretenden Rezidive sind für die relativ niedrige überlebenserwartung des Magenkarzinoms verantwortlich (10 Jahre: 12% Ries et al. 1990).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aarnio M, Salovaara R, Aaltonen LA, Mecklin J-P, Järvinen HJ (1997) Features of gastric cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 74:551–555PubMedGoogle Scholar
  2. Akama Y, Yasui W, Yokozaki H et al. (1995) Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 86:617–621PubMedGoogle Scholar
  3. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T (1986) The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 233:1644–1646Google Scholar
  4. Akiyama Y, Sato H, Yamada T et al. (1997) Germ-line mutation of the hMSH6/GTBP gene in an a typical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 57:3920–3923PubMedGoogle Scholar
  5. Allgayer H, Heiss MM, Schildberg FW (1997) Prognostic factors in gastric cancer. Br J Surg 84:1651–1664PubMedGoogle Scholar
  6. Allgayer H, Babic R, Grutzner KU et al. (1998) Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns. Clin Exp Metastasis 16:62–73PubMedGoogle Scholar
  7. Antonioli D (1994) Precursors of gastric carcinoma. Hum Pathol 25:994–1005PubMedGoogle Scholar
  8. Ayhan A, Yasui W, Yokozaki H, Seto M, Ueda R, Tahara E (1994) Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. Jpn J Cancer Res 85:584–591PubMedGoogle Scholar
  9. Becker K-F, Atkinson MJ, Reich U et al. (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54:3845–3852PubMedGoogle Scholar
  10. Becker I, Becker K-F, Röhrl MH, Minkus G, Schütze K, Höfler H (1996) Single-cell mutation analysis of tumors from stained histologic slides. Lab Invest 75:801–807PubMedGoogle Scholar
  11. Becker K-F, Kremmer E, Eulitz M et al. (1999) Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. Am J Pathol 155:1803–1809PubMedCentralPubMedGoogle Scholar
  12. Berx G, Cleton-Jansen AM, Strumane K et al. (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919–1925PubMedGoogle Scholar
  13. Berx G, Becker K-F, Höfler H, Roy F van (1998) Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12:226–237PubMedGoogle Scholar
  14. Böttcher K, Roder J, Busch R et al. (1993) Epidemiologic des Magenkarzinoms aus chirurgischer Sicht-Ergebnisse der Deutschen Magen-Karzinom Studie 1992. Dtsch Med Wochensehr 118:729–736Google Scholar
  15. Borrmann R (1926) Geschwulste des Magens und Duodenums. In: Henke F, Lubarch O (eds) Handbuch der speziellen pathologischen Anatomie und Histologie, Bd 4. Springer, Berlin Heidelberg New York, S 865–879Google Scholar
  16. Buonsanti G, Calistri D, Padovan L et al. (1997) Microsatellite instability in intestinal-and diffuse-type gastric carcinoma. J Pathol 182:167–173PubMedGoogle Scholar
  17. Caldas C, Carneiro F, Lynch HT et al. (1999) Familial gastric cancer: overview and guidelines for management. J Med Genet 36:873–880PubMedCentralPubMedGoogle Scholar
  18. Candidus S, Bischoff P, Becker K-F, Höfler H (1996) No evidence for mutations in alpha and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 56:49–52PubMedGoogle Scholar
  19. Carriaga M, Henson D (1995) The histologic grading of cancer. Cancer 75:406–421PubMedGoogle Scholar
  20. Correa P, Shiao Y-H (1994) Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res [Suppl] 54:1941s–1943sPubMedGoogle Scholar
  21. Correa P, Cuello C, Duque E (1970) Carcinoma and intestinal metaplasia of the Stomach in Columbian migrants. J Natl Cancer Inst 44:297PubMedGoogle Scholar
  22. Dittler HJ, Siewert JR (1993) Role of endoscopic ultrasonography in gastric carcinoma. Endoscopy 25:162PubMedGoogle Scholar
  23. Dos Santos NR, Seruca R, Constancia M, Scixas M, Sobrinho-Simoes M (1996) Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologie implications and prognosis. Gastroenterology 110:38–44PubMedGoogle Scholar
  24. Engel J, Hölzel D, Reimer B (1997) Epidemiologie gastrointestinaler Tumoren. In: Projektgruppe Gastrointestinale Tumoren (Hrsg) Empfehlungen zur Diagnostik, Therapic und Nachsorge, 5. Aufl. Tumorzentrum, München, S 5–9Google Scholar
  25. Entius MM, Westerman AM, Velthuysen M-LF van et al.(1999) Molecular and phenotypic markers of hamartomatous polyposis syndromes in the gastrointestinal tract. Hepatogastroenterology 46:661–666PubMedGoogle Scholar
  26. Fenoglio-Preiser C (1997) Gastrointestinal pathology, 2nd edn. Raven Press, New YorkGoogle Scholar
  27. Feussner H, Kraemer SJM, Siewert JR (1997) Staging-Laparoskopie. Chirurg 68:201PubMedGoogle Scholar
  28. Fuch CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333:32–41Google Scholar
  29. Gabbert HE, Meier S, Gerharz CD, Hommel G (1991) Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int J Cancer 49:203–207PubMedGoogle Scholar
  30. Gabbert HE, Meier S, Gerharz CD, Hommel G (1992) Tumor-cell dissociation at the invasive front: a new prognostic parameter in gastric cancer patients. Int J Cancer 50:202–207PubMedGoogle Scholar
  31. Gayther SA, Gorring KL, Susan JR et al. (1998) Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58:4086–4089PubMedGoogle Scholar
  32. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SE (1996) Widespread microsatellite instability occurs infrequently in adenocarcinoma of the gastric cardia. Oncogene 12:1653–1662PubMedGoogle Scholar
  33. Grad A (1984) Carcinoma of the resected stomach. In: Ming SC (ed) Precursors of gastric cancer. Praeger, Philadelphia, pp 287–313Google Scholar
  34. Groden J, Thilveris A, Samowitz W et al. (1991) Identification and characterization of the familial adenomatous polyposis coligene. Cell 66:589–600PubMedGoogle Scholar
  35. Guilford P, Hopkins J, Harraway J et al. (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402–405PubMedGoogle Scholar
  36. Guilford P, Hopkins JBW, Grady WM et al. (1999) E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 14:249–255PubMedGoogle Scholar
  37. Handschuh G, Candidus S, Luber B et al. (1999) Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 18:4301–4312PubMedGoogle Scholar
  38. Harrison LE, Zhang ZF, Karpeh MS, Sun M, Kurtz RC (1997) The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma. A case-control study in the U. S. Cancer 80:1021–1028Google Scholar
  39. Heiss MM, Allgayer H, Gruetzner KU et al. (1995) Individual development and uPA-receptor expression of disseminated tumor cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med 1:1035–1039PubMedGoogle Scholar
  40. Hermanek P, Wittekind C (1994) Residual tumor (R) classification and prognosis. Semin Surg Oncol 10:12–20PubMedGoogle Scholar
  41. Hermanek P, Henson D, Hutter R, Sobin L (eds) (1993) UICC: TNM supplement 1993-A commentary on uniform use. Springer, Berlin Heidelberg New YorkGoogle Scholar
  42. Hermanek P, Gospodarowicz M, Henson D, Hutter R, Sobin L (eds) (1995) Prognostic factors in cancer, 1st edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  43. Hofgartner WT, Thorp M, Ramus MW et al. (1999) Gastric adenocarcinoma associated with fundie gland polyps in a patient with attenuated familial adenomatous polyposis.Am J Gastroenterol 94:2275–2281PubMedGoogle Scholar
  44. Horii A, Nakatsuru S, Miyoshi Y et al. (1992) The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res 52:3231–3233Google Scholar
  45. Horio Y, Suzuki H, Ueda R (1994) Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. Oncogene 9:1231–1235PubMedGoogle Scholar
  46. Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153:333–339PubMedCentralPubMedGoogle Scholar
  47. Inoue K, Tobe T, Kan N et al. (1991) Problems in the definition and treatment of early gastric cancer. Br J Surg 78:818–821PubMedGoogle Scholar
  48. Iriyama K, Miki C, Ilunga K, Osawa T, Tsuchibashi T, Suzuki H (1993) Prognostic significance of histological type in gastric carcinoma with invasion confined to the stomach wall. Br J Surg 80:890–892PubMedGoogle Scholar
  49. Japanese Research Society for Gastric Cancer (1981) The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 11:127–145Google Scholar
  50. Kameda T, Yasui W, Yoshida K et al. (1990) Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. Cancer Res 50:8002–8009PubMedGoogle Scholar
  51. Keller G, Grimm V, Vogelsang H et al. (1996) Analysis for microsatellite instability and mutations in the DNA mismatch repair gene hMLHI in familial gastric cancer. Int J Cancer 68:571–576PubMedGoogle Scholar
  52. Keller G, Rudelius M, Vogelsang H et al. (1998) Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history. Am J Pathol 152:1281–1289PubMedCentralPubMedGoogle Scholar
  53. Keller G, Vogelsang H, Becker I et al. (1999) Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155:337–342PubMedCentralPubMedGoogle Scholar
  54. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: abasie biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMedCentralPubMedGoogle Scholar
  55. Kim JH, Takahashi T, Chiba I et al. (1991) Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst 83:938–943PubMedGoogle Scholar
  56. Kleihues P, Schäubele B, Hausen Azur, Esteve J, Ohgaki H (1997) Tumors associated with p53 germline mutations. A synopsis of 91 families. Am J Pathol 150: 1–13PubMedCentralPubMedGoogle Scholar
  57. Klein RF, Vollmers HP, Müller-Hermelink HK (1994) Different expression of bcl-2 in diffuse and intestinal type stomach carcinomas. Oncol Rep 69:943–946Google Scholar
  58. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E (1992) Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 189:227–232PubMedGoogle Scholar
  59. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y, Tahara E (1993) Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 55:72–75PubMedGoogle Scholar
  60. Laurén P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31–49PubMedGoogle Scholar
  61. La Vecchia C, Negri E, Franceschi S, Gentile A (1992) Family his tory and the risk of stomach and colorectal cancer. Cancer 70:50–55PubMedGoogle Scholar
  62. Leach SA, Thompson M, Hill M (1987) Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach. Carcinogenesis 8:1907–1912PubMedGoogle Scholar
  63. Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418PubMedGoogle Scholar
  64. Maruyama M, Takeshita K, Endo M, Deakin M, Moossa AR (1999) Clinicopathological study of gastric carcinoma in high-and low-mortality count ries: comparison between Japan and the United States. Gastric Cancer 1:64–70Google Scholar
  65. Ming S (1977) Gastric carcinoma: a pathobiological classification. Cancer 39:2475–2485PubMedGoogle Scholar
  66. Ming S (1998) Pathology and genetics of gastric cancer. Gastric Cancer 1:31–50PubMedGoogle Scholar
  67. Miyaki M, Konishi M, Tanaka K et al. (1997) Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17:271–272PubMedGoogle Scholar
  68. Moutinho-Ribeiro M, Scixas M, Sobrinho-Simoes M (1988) Prognosis in gastric carcinoma: the preeminence of staging and the futility of histological classification. In: Watanabe S, Wolff M, Sommers S (eds) Digestive disease pathology, Bd I. Springer, Berlin Heidelberg New York, pp 51–68Google Scholar
  69. Murakami T (1971) Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. Gann Monogr Cancer Res 11:53–55Google Scholar
  70. Nakamura S, Ueli T, Yao T, Reyama T, Tsundeyoshi M (1994) Epstein Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain re action and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer 73:2239–2249PubMedGoogle Scholar
  71. Nakatsuru S, Yanagisawa A, Ichii S et al. (1992) Somatic mutation of the APC gene in gastric cancer: frequent mutations in very weil differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1:559–563PubMedGoogle Scholar
  72. Nekarda H, Schmitt M, Ulm K et al. (1994) Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res 54:2900–2907PubMedGoogle Scholar
  73. Nomura A, Stemmermann GN, Chyou PH et al. (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325: 1132–1136PubMedGoogle Scholar
  74. Oda T, Kanai Y, Oyama T et al. (1994) E-Cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91:1858–1862PubMedCentralPubMedGoogle Scholar
  75. Offerhaus GJA, Entius MM, Giardello FM (1999) Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology 46:667–669PubMedGoogle Scholar
  76. Ohgami M, Kumai K, Wakabayashi G, Otani Y (1993) Innovative treatment for early gastric cancer: laparoscopic wedge resection of the Stomach using the lesion-lifting method. Stomach Intestine 28:1461Google Scholar
  77. Okusa T, Nakane Y, Boku T et al. (1990) Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surgery 170:488–494Google Scholar
  78. Okusa Y, Ichikura T, Mochizuki H (1999) Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma. Cancer 85:1033–1038PubMedGoogle Scholar
  79. Palli D, Galli M, Caporaso NE et al. (1994) Family history and risk of Stomach cancer in Italy. Cancer Epidemiol Biomarkers Prevent 3:15–18Google Scholar
  80. Park WS, Oh RR, Park JY (1999) Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 59:4257–4260PubMedGoogle Scholar
  81. Parsonnet J, Friedman GD, Vandersteen DP et al. (1991) Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMedGoogle Scholar
  82. Peifer M (1999) Neither straight nor narrow. Science 400: 213–215Google Scholar
  83. Peltomäkie P, Vasen HFA, and The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (1997) Mutations predisposing to hereditary colorectal cancer: database and results of a collaborative study. Gastroenterology 113:1146–1158Google Scholar
  84. Raff M (1998) Cell suicide for beginners. Nature 396:199–212Google Scholar
  85. Richards FM, McKee SA, Rajpar MH et al. (1999) Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 8:607–610PubMedGoogle Scholar
  86. Ries LAG, Hankey BF, Edwards BK (1990) Cancer statistics review 1973-1987. NIH Publication 90–2789Google Scholar
  87. Roder JD, Böttcher K, Siewert JR et al. (1993) Prognostic factors in gastric carcinoma: results of the German Gastric Carcinoma Study. Cancer 72:2090–2097Google Scholar
  88. Rösch W (1989) Endoskopische Kriterien der prämalignen Läsionen und des Magenfrühkarzinoms. In: Hotz J, Meyer H-J, Schmoll H (eds) Magenkarzinom. Klassifikation, Diagnostik und stadiengerechte Therapic. Springer, Berlin Heidelberg New YorkGoogle Scholar
  89. Rösch T (1995) Endosonographic staging of gastric cancer: a review of literature results. Gastrointest Clin North Am 3:59Google Scholar
  90. Rugge M, Farinati F, Baffa R et al. (1994) Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter follow-up study. Gastroenterology 107:1288PubMedGoogle Scholar
  91. Saini S (1997) Imaging of the hepatobiliary tract. N Engl J Med 336:1889PubMedGoogle Scholar
  92. Sano T, Tsujino T, Yoshida K et al. (1991) Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 51:2926–2931PubMedGoogle Scholar
  93. Schuhmacher C, Becker KF, Reich U et al. (1999) Rapid detection of mutated E-cadherin in peritoneal lavage specimens from patients with diffuse-type gastric carcinoma.Diagn Mol Pathol 8:66–70PubMedGoogle Scholar
  94. Siewert JR, Böttcher K, Bollschweiler E (1991) TNM-Klassifikation bei Magenkarzinom-das Problem der T2-Tumoren. Dtsch Med Wochenschr 116:473–475PubMedGoogle Scholar
  95. Siewert JR, Kestlmeier R, Busch R, Böttcher K (1996) Benefits of D2 lymph node dissection for patients with gastric cancer and pNO and pN1 lymph node metastases. Br J Surg 83:1144PubMedGoogle Scholar
  96. Siewert JR, Böttcher K, Stein H, Roder JD (1998) Relevant prognostic factors in gastric cancer. Ann Surg 228:449PubMedCentralPubMedGoogle Scholar
  97. Sobin L, Wittekind ED (1997) UICC: TNM classification of malignant tumours, 5th edn. John Wiley & Sons, New YorkGoogle Scholar
  98. Stemmermann G, Heffelfinger SC, Noffsinger A, Hui Y.Z., Miller MA, Fenoglio-Preiser CM (1994) The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol 25:968–981PubMedGoogle Scholar
  99. Suarez-Quian CA, Goldstein SR, Pohida T et al. (1999) Laser capture microdissection of single cells from complex tissues. Biotechniques 26:328–335PubMedGoogle Scholar
  100. Tahara E (1993) Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119:265–272PubMedGoogle Scholar
  101. Tahara E (1995) Genetic alterations in human gastrointestinal cancers. Cancer 75:1410–1417PubMedGoogle Scholar
  102. Tahara E (1997) Molecular prognostic factors of gastric cancer. Proceedings Of The 2Nd International Gastric Cancer Congress 1997, Munich. Monduzzi, Bologna, pp 371–377Google Scholar
  103. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451–1457PubMedGoogle Scholar
  104. Taniwaga N, Amaya H, Matsumura M et al. (1996) Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 56:2671–2676Google Scholar
  105. The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310–1316Google Scholar
  106. Thompson GB, Heerden JA, Sarr MG (1993) Adenocarcinoma of the stomach: are we making progress? Lancet 342:713–718PubMedGoogle Scholar
  107. Tsugawa K, Fushida S, Yonemura Y (1993) Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival. Oncology 50:418–425PubMedGoogle Scholar
  108. Uchino S, Tsuda H, Noguchi M et al. (1992) Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52:3099–3102PubMedGoogle Scholar
  109. Uchino S, Tsuda H, Maruyama K et al. (1993) Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Cancer 72:3179–3184PubMedGoogle Scholar
  110. Vollmers HP, Dammrich J, Hensel F (1997) Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma. Cancer 79:433–440PubMedGoogle Scholar
  111. Vollmers HP, Zimmermann U, Krenn V et al. (1998) Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-I: first clinical and histopathological results. Oncol Rep 5:549–552PubMedGoogle Scholar
  112. Watanabe H, Enjoji M, Yao T, Ohsato K (1978) Gastric lesions in familial adenomatosis coli. Hum Pathol 9:269–282PubMedGoogle Scholar
  113. Watanabe H, Jass JR, Sobin SH (1990) World Health Organization. International Histological Classification of Tumors: histological typing of oesophageal and gastric tumours. Springer, Berlin Heidelberg New YorkGoogle Scholar
  114. Watson P, Lynch HT (1993) Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677–685PubMedGoogle Scholar
  115. Werner M, Nasarek A, Georgii A (1996) Isolated tumor cells in the bone marrow: value of a new diagnostic method in the TNM staging of solid tumors. Gen Diagn Pathol 142:1–6PubMedGoogle Scholar
  116. Wright PA, Williams GT (1993) Molecular biology and gastric carcinoma. Gut 34:145–147PubMedCentralPubMedGoogle Scholar
  117. Wright PA, Quirke P, Attanoos R, Williams GT (1992) Molecular pathology of gastric carcinoma: progress and prospects. Hum Pathol 23:848–859PubMedGoogle Scholar
  118. Yamada Y, Yoshida T, Hayashi K et al. (1991) p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res 51:5800–5805PubMedGoogle Scholar
  119. Yasui W, Yokosaki H, Kuniyasu H et al. (1996) Expression of CDK inhibitor pI6(CDKN2/MTS1/INK4A) in human gastric carcinomas. In: Tahara E, Sugimachi K, Oohara T (eds) Recent advances in gastroenterological carcinogenesis. Monduzzi, Bologna, pp 765–769Google Scholar
  120. Yonemura Y, Ninomiya I, Yamaguchi A et al. (1991) Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 51:1034–1038PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • Martin Werner
  • Karl Friedrich Becker
  • Knut Böttcher
  • Gisela Keller
  • Heinz Höfler

There are no affiliations available

Personalised recommendations